Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Iron Sucrose Injection vs Venofer in Healthy Adults
NCT04155814Phase 1Completed
- Sponsor
- Baxter
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of iron sucrose in iron deficiency anemia (IDA) (2 arms), sponsored by Baxter. Primary endpoints: Maximum concentration (delta) and Area Under the Curve to last timepoint (delta). Started Sep 2019; status: completed.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04155814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155814.